摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1H-吲哚-3-基)(3-苯基-1,2,4-恶二唑-5-基)甲酮 | 1023731-28-3

中文名称
(1H-吲哚-3-基)(3-苯基-1,2,4-恶二唑-5-基)甲酮
中文别名
——
英文名称
(1H-indol-3-yl)(3-phenyl-1,2,4-oxadiazol-5-yl)methanone
英文别名
——
(1H-吲哚-3-基)(3-苯基-1,2,4-恶二唑-5-基)甲酮化学式
CAS
1023731-28-3
化学式
C17H11N3O2
mdl
——
分子量
289.293
InChiKey
YQOCLEXUZFXBQE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    258-260 °C
  • 沸点:
    542.0±42.0 °C(predicted)
  • 密度:
    1.348±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.45
  • 重原子数:
    22.0
  • 可旋转键数:
    3.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    71.78
  • 氢给体数:
    1.0
  • 氢受体数:
    4.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1H-吲哚-3-基)(3-苯基-1,2,4-恶二唑-5-基)甲酮N-(2-氯乙基)吗啉盐酸盐 在 sodium hydride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 8.0h, 以25.76%的产率得到[1-(2-Morpholin-4-ylethyl)indol-3-yl]-(3-phenyl-1,2,4-oxadiazol-5-yl)methanone
    参考文献:
    名称:
    Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: Novel agonists for the CB1 receptor
    摘要:
    An exploratory chemical effort has been undertaken to develop a novel series of compounds as selective CB1 agonists. It is hoped that compounds of this type will have clinical utility in pain control, and cerebral ischaemia following stroke or traumatic head injury.We report here medicinal chemistry studies directed towards the investigation of a series of 1-substituted-indole-3-oxadiazoles as potential CB, agonists. Crown Copyright (c) 2007 Published by Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2007.04.007
  • 作为产物:
    描述:
    苯甲酰胺肟3-吲哚乙醛酸 在 3 A molecular sieve 、 sodium hydride 、 N,N'-羰基二咪唑 作用下, 以 四氢呋喃 为溶剂, 反应 4.0h, 以44.15%的产率得到(1H-吲哚-3-基)(3-苯基-1,2,4-恶二唑-5-基)甲酮
    参考文献:
    名称:
    Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: Novel agonists for the CB1 receptor
    摘要:
    An exploratory chemical effort has been undertaken to develop a novel series of compounds as selective CB1 agonists. It is hoped that compounds of this type will have clinical utility in pain control, and cerebral ischaemia following stroke or traumatic head injury.We report here medicinal chemistry studies directed towards the investigation of a series of 1-substituted-indole-3-oxadiazoles as potential CB, agonists. Crown Copyright (c) 2007 Published by Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2007.04.007
点击查看最新优质反应信息